Results 111 to 120 of about 449,349 (233)
PLoS ONE, 2019 99m-Technetium-labeled (99mTc) erythrocyte imaging with planar scintigraphy is widely used for evaluating both patients with occult gastrointestinal bleeding and patients at risk for chemotherapy-induced cardiotoxicity.
Jung W Choi +5 more
doaj +1 more source
Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications. [PDF]
Pharmaceutics, 2022 Kwon D +5 more
europepmc +1 more source
Inorganics, 2019 Lanthanide-doped upconverting nanoparticles (UCNPs) transform near infrared light (NIR) into higher-energy UV and visible light by multiphotonic processes.
Silvia Alonso-de Castro +9 more
doaj +1 more source
Computational modeling of PET imaging agents for vesicular acetylcholine transporter (VAChT) protein binding affinity: application of 2D-QSAR modeling and molecular docking techniques. [PDF]
In Silico Pharmacol, 2023 De P, Roy K.
europepmc +1 more source
Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology. [PDF]
, 2019 It is estimated that more than 6 million pet dogs are diagnosed with cancer annually in the USA. Both primary care and specialist veterinarians are frequently called upon to provide clinical care that improves the quality and/or quantity of life for ...
Boss, Mary-Keara +2 more
core
Neurobiology of DiseaseMultiple system atrophy (MSA) is a complex, heterogeneous neurodegenerative disorder characterized by a multifaceted pathogenesis. Its key pathological hallmark is the abnormal aggregation of α-synuclein, which triggers neuroinflammation, disrupts both ...
La Dong +9 more
doaj +1 more source
Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents. [PDF]
ACS Pharmacol Transl Sci, 2021 Pickel TC +9 more
europepmc +1 more source
Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. [PDF]
, 2020 BACKGROUND:Breast cancer patients with early-stage disease are increasingly administered neoadjuvant chemotherapy (NAC) to downstage their tumors prior to surgery. In this setting, approximately 31% of patients fail to respond to therapy.
Cabral, Howard +11 more
core